Citations

Clear

4 citation(s) found for "Simon, Christian".

Radiological Insights into Alcohol Use Associated Disorders and Diseases: Part I
Nduwimana, Marie-Joy, Maheshwari, Sharad, Pratap, Thara , Helavar, Rajesh V, Patil, Aruna R., Rawat, Sudarshan, Khandelwal, Ashish , Menias, Christine O. , Venkatesh, Sudhakar K. , Venkatesh, Sudhakar K , Simon, Betty

Mayo Clinic

Indian Journal of Radiology and Imaging | February 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0045-1813745 Get It

Alcohol use disorder (AUD) is a significant public health challenge, affecting multiple organs and organ systems, and fetal health. Additionally, AUD also significantly contributes to self-harm and road accidents. Beyond its health effects, AUD creates economic and political challenges, including escalating treatment costs and the complex alcohol regulation policies. Despite global impact, AUD remains under-addressed in countries like India due to cultural norms and limited resources. Early recognition of AUD is vital for better outcomes, relying on thorough clinical evaluation and patient history. However, denial, inebriation, or lack of awareness often delays diagnosis. Imaging techniques like ultrasound, CT, and MRI effectively depict AUD-related organ damage and aid in detecting chronic alcohol use. Radiologists play a crucial role in identifying these manifestations, contributing to its early detection and treatment. This review article highlights the imaging of alcohol use related disorders and diseases affecting different organs and organ systems at various stages. The review is presented in two parts: the first focuses on alcohol burden, alcohol metabolism and toxicity, and imaging findings of AUD-related abdominal diseases and disorders.
Peripherally-derived LGI1-reactive monoclonal antibodies cause epileptic seizures in vivo
Upadhya, Manoj A. , Kirmann, Toni , Wilson, Max A , Simon, Christian M. , Dhangar, Divya , Williams, Robyn , Woodhall, Gavin L. , Hallermann, Stefan , Irani, Sarosh R. , Wright, Sukhvir , Woodhall, Gavin , Irani, Sarosh R , Wright, Sukhvir K , Geis, Christian

Mayo Clinic

Brain | April 23, 2024 | Volume: 147 | Issue: 8 | Pages: 2636-2642

10.1093/brain/awae129 | PMID 38662480 Get It

Abstract One striking clinical hallmark in patients with autoantibodies to leucine-rich glioma inactivated 1 (LGI1) is the very frequent focal seizure semiologies, including faciobrachial dystonic seizures (FBDS), in addition to the amnesia. Polyclonal serum IgGs have successfully modelled the cognitive changes in vivo but not seizures. Hence, it remains unclear whether LGI1-autoantibodies are sufficient to cause seizures. We tested this with the molecularly precise monoclonal antibodies directed against LGI1 [LGI1-monoclonal antibodies (mAbs)], derived from patient circulating B cells. These were directed towards both major domains of LGI1, leucine-rich repeat and epitempin repeat, and infused intracerebroventricularly over 7 days into juvenile male Wistar rats using osmotic pumps. Continuous wireless EEG was recorded from a depth electrode placed in hippocampal CA3 plus behavioural tests for memory and hyperexcitability were performed. Following infusion completion (Day 9), post-mortem brain slices were studied for antibody binding and effects on Kv1.1. The LGI1-mAbs bound most strongly in the hippocampal CA3 region and induced a significant reduction in Kv1.1 cluster number in this subfield. By comparison to control-Ab injected rats video-EEG analysis over 9 days revealed convulsive and non-convulsive seizure activity in rats infused with LGI1-mAbs, with a significant number of ictal events. Memory was not impaired in the novel object recognition test. Peripherally-derived human LGI1-mAbs infused into rodent CSF provide strong evidence of direct in vivo epileptogenesis with molecular correlations. These findings fulfill criteria for LGI1-antibodies in seizure causation.
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study
Hardman, John , Holsinger, F. Christopher , Brady, Grainne , Beharry, Avinash , Bonifer, Alec , D’Andréa, Grégoire , Dabas, Surender, Almeida, John R. de , Duvvuri, Umamaheswar , Floros, Peter , Ghanem, Tamer , Hamilton, David W. , Larsen, Mikkel Hjordt Holm , Magnuson, J. Scott , Miles, Brett A., Moore, Eric J. , Pantvaidya, Gouri , Rubek, Niclas , Simon, Christian , Abel, Kathryn M. Van , Poorten, Vincent Vander , Walgama, Evan , Greenlay, Emily, Potts, Laura, Balaji, Arun, Starmer, Heather M. , Stephen, S. , Roe, Justin , Harrington, Kevin J. , Paleri, Vinidh , Hardman, John C , Holsinger, F Chris , Brady, Grainne C , Bonifer, Alec T , de Almeida, John R , Ghanem, Tamer A , Gorphe, Philippe , Gross, Neil D , Hamilton, David , Kurukulasuriya, Chareeni , Larsen, Mikkel Hjordt Holm , Lin, Daniel J , Magnuson, J Scott , Meulemans, Jeroen , Miles, Brett A , Moore, Eric J , Pantvaidya, Gouri , Roof, Scott , Rubek, Niclas , Subash, Anand , Topf, Michael C , Van Abel, Kathryn M , Vander Poorten, Vincent , Walgama, Evan S , Greenlay, Emily , Potts, Laura , Balaji, Arun , Roe, Justin , Harrington, Kevin , Paleri, Vinidh , Topf, Michael C.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 9, 2022 | Volume: 114 | Issue: 10 | Pages: 1400-1409

10.1093/jnci/djac130 | PMID 35944904 Get It

Abstract Background Transoral robotic surgery (TORS) is an emerging minimally invasive surgical treatment for residual, recurrent, and new primary head and neck cancers in previously irradiated fields, with limited evidence for its oncological effectiveness. Methods A retrospective observational cohort study of consecutive cases performed in 16 high-volume international centers before August 2018 was conducted (registered at clinicaltrials.gov [NCT04673929] as the RECUT study). Overall survival (OS), disease-free survival, disease-specific survivals (DSS), and local control (LC) were calculated using Kaplan-Meier estimates, with subgroups compared using log-rank tests and Cox proportional hazards modeling for multivariable analysis. Maximally selected rank statistics determined the cut point for closest surgical resection margin based on LC. Results Data for 278 eligible patients were analyzed, with median follow-up of 38.5 months. Two-year and 5-year outcomes were 69.0% and 62.2% for LC, 71.8% and 49.8% for OS, 47.2% and 35.7% for disease-free survival, and 78.7% and 59.1% for disease-specific survivals. The most discriminating margin cut point was 1.0 mm; the 2-year LC was 80.9% above and 54.2% below or equal to 1.0 mm. Increasing age, current smoking, primary tumor classification, and narrow surgical margins (≤1.0 mm) were statistically significantly associated with lower OS. Hemorrhage with return to theater was seen in 8.1% (n = 22 of 272), and 30-day mortality was 1.8% (n = 5 of 272). At 1 year, 10.8% (n = 21 of 195) used tracheostomies, 33.8% (n = 66 of 195) used gastrostomies, and 66.3% (n = 53 of 80) had maintained or improved normalcy of diet scores. Conclusions Data from international centers show TORS to treat head and neck cancers in previously irradiated fields yields favorable outcomes for LC and survival. Where feasible, TORS should be considered the preferred surgical treatment in the salvage setting.
The cobas® 6800/8800 System: a new era of automation in molecular diagnostics
Cobb, Bryan, Simon, Christian O., Body, Barbara A., Mitchell, P. Shawn, Reisch, Nataša, Stevens, Wendy , Carmona, Sergio , Katz, Louis N., Will, Stephen, Liesenfeld, Oliver , Stramer, Susan L. , Katz, Louis

Mayo Clinic

Expert Review of Molecular Diagnostics | January 3, 2017 | Volume: 17 | Issue: 2 | Pages: 167-180

10.1080/14737159.2017.1275962 | PMID 28043179 Get It